Heartware International Inc (HTWR)

57.89
NASDAQ : Health Care
Prev Close 57.89
Day Low/High 0.00 / 0.00
52 Wk Low/High 25.02 / 94.15
Avg Volume 640.40K
Exchange NASDAQ
Shares Outstanding 17.54M
Market Cap 1.02B
EPS -4.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of HeartWare International, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of HeartWare International, Inc. And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

HeartWare (HTWR) Stock Continues to Surge on Medtronic Deal

HeartWare (HTWR) Stock Continues to Surge on Medtronic Deal

HeartWare (HTWR) stock is skyrocketing Monday afternoon after the medical device company agreed to be acquired by Medtronic (MDT) for about $1.1 billion.

HEARTWARE INTERNATIONAL, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Medtronic Plc

HEARTWARE INTERNATIONAL, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Medtronic Plc

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of HeartWare...

Medtronic Acquires HeartWare With Some Activist Inspiration

Medtronic Acquires HeartWare With Some Activist Inspiration

Engaged Capital agitated against the cardiac medical device maker's buy of an Israeli company and pushed for a new board member that once led the acquirer's M&A efforts.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of HeartWare International, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of HeartWare International, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

Jim Cramer on the Medtronic-HeartWare Deal

Jim Cramer on the Medtronic-HeartWare Deal

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said Medtronic's $1.1 billion proposed acquisition of HeartWare International on Monday is a smart deal.

3 Health Care Stocks Nudging The Sector Higher

3 Health Care Stocks Nudging The Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

Midday Report: McDonald's Price Cut; Stocks in 'Brexit' Selloff

Midday Report: McDonald's Price Cut; Stocks in 'Brexit' Selloff

U.S. stocks extended their declines, piling on heavy losses suffered at the end of last week, as markets continued to react to the pro-exit vote from the U.K.

Stock Losses Accelerate as 'Brexit' Causes Chaos

Stock Losses Accelerate as 'Brexit' Causes Chaos

Stock losses accelerate by late morning Monday as the fallout from Friday's 'Brexit' vote punishes global markets.

HeartWare (HTWR) Stock Skyrocketing on Medtronic Deal

HeartWare (HTWR) Stock Skyrocketing on Medtronic Deal

HeartWare (HTWR) stock is soaring on Monday morning after the company agreed to be bought by Medtronic (MDT) for about $1.1 billion.

Jim Cramer -- Medtronic Has Become an 'Unassailable' Powerhouse

Jim Cramer -- Medtronic Has Become an 'Unassailable' Powerhouse

Medtronic started its drive after buying Covidien and switching its tax base to Ireland. Now it's buying Heartware International, Cramer says.

Stock Futures Point to Another Dark Day Over 'Brexit'

Stock Futures Point to Another Dark Day Over 'Brexit'

Stock futures point to another day in the red on Monday, piling on heavy losses suffered at the end of last week.

Today's Pre-Market Mover With Heavy Volume: Heartware International (HTWR)

Today's Pre-Market Mover With Heavy Volume: Heartware International (HTWR)

Trade-Ideas LLC identified Heartware International (HTWR) as a pre-market mover with heavy volume candidate

Perilous Reversal Stock: Heartware International (HTWR)

Perilous Reversal Stock: Heartware International (HTWR)

Trade-Ideas LLC identified Heartware International (HTWR) as a "perilous reversal" (up big yesterday but down big today) candidate

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

- Clinical Trial Evaluates Less-Invasive Thoracotomy Implant Technique of the HVAD System in Patients with Advanced Heart Failure -

Commit To Purchase Heartware International At $17.50, Earn 10.5% Annualized Using Options

Commit To Purchase Heartware International At $17.50, Earn 10.5% Annualized Using Options

Investors eyeing a purchase of Heartware International Inc shares, but cautious about paying the going market price of $35.70/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $17.50 strike, which has a bid at the time of this writing of $1.20.

HeartWare Announces HVAD® System Scientific Presentations At The International Society For Heart And Lung Transplantation 36th Annual Meeting

HeartWare Announces HVAD® System Scientific Presentations At The International Society For Heart And Lung Transplantation 36th Annual Meeting

- HeartWare to Host Scientific Symposiums on HVAD System Waveforms and Advancements in HVAD System Outcomes -

What's Next for These 5 Companies Targeted by Activist Investor Glenn Welling?

What's Next for These 5 Companies Targeted by Activist Investor Glenn Welling?

Glen Welling's Engaged Capital has targeted Outerwall, Heartware, Magnachip, Jamba Juice and Benchmark Electronics. Here's his plans for each company.

March 22 Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors Of The Lead Plaintiff Deadline In The Class Action Lawsuit Against HeartWare International, Inc.

March 22 Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors Of The Lead Plaintiff Deadline In The Class Action Lawsuit Against HeartWare International, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming March 22, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class") of investors who...